Neuberger Berman Group’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Hold |
12,656
| – | – | ﹤0.01% | 2024 |
|
|
2025
Q1 | $19.4K | Hold |
12,656
| – | – | ﹤0.01% | 1933 |
|
|
2024
Q4 | $31.4K | Hold |
12,656
| – | – | ﹤0.01% | 1893 |
|
|
2024
Q3 | $14.6K | Hold |
12,656
| – | – | ﹤0.01% | 1904 |
|
|
2024
Q2 | $13.9K | Buy |
12,656
+141
| +1% | +$155 | ﹤0.01% | 1882 |
|
|
2024
Q1 | $15.5K | Sell |
12,515
-5,704
| -31% | -$7.07K | ﹤0.01% | 1811 |
|
|
2023
Q4 | $19.1K | Buy |
+18,219
| New | +$19.1K | ﹤0.01% | 1833 |
|
|
2017
Q2 | – | Sell |
-40,000
| Closed | -$1.19M | – | 1578 |
|
|
2017
Q1 | $1.19M | Buy |
40,000
+27,000
| +208% | +$805K | ﹤0.01% | 1104 |
|
|
2016
Q4 | $353K | Hold |
13,000
| – | – | ﹤0.01% | 1368 |
|
|
2016
Q3 | $333K | Buy |
+13,000
| New | +$333K | ﹤0.01% | 1369 |
|